Efficacy analysis of valsartan combined with salvia tetramethylpyrazine in the treatment of early diabetic nephropathy
10.3760/cma.j.issn.1008-6706.2013.10.020
- VernacularTitle:缬沙坦联合丹参川芎嗪治疗早期糖尿病肾病的疗效分析
- Author:
Shilong WANG
;
Rui ZHANG
- Publication Type:Journal Article
- Keywords:
Valsartan;
Salvia tetramethylpyrazine;
Diabetic nephropathy
- From:
Chinese Journal of Primary Medicine and Pharmacy
2013;20(10):1485-1486
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the effect of valsartan combined with salvia miltiorrhiza ligustrazine in treating early diabetic nephropathy(DN),looking for an effective method for the treatment of early DN.Methods 51 DN patients were divided into two groups,28 cases in the treatment group were treated with valsartan and salvia miltiorrhiza ligustrazine therapy,23 cases in the control group only received valsartan treatment.Fasting blood glucose before and after treatment (FPG),2h postprandial blood glucose (2hPG),glycosylated hemoglobin (HbA1 c),BUN,Scr,urine albumin excretion rate(UAER) index were detected.Results Before and after treatment,FPG,2hPG,HbA1c,UAER in the two groups had statistically significant differences (t =5.361,6.458,3.026,7.894,5.648,7.604,6.590,8.652,all P ＜ 0.05).After treatment,2hPG,HbA1c,UAER between the two groups had statistically significant differences (t =3.125,3.520,3.881,all P ＜ 0.05).No statistical difference was observed before and after treatment in two groups of BUN,Scr (P ＞ 0.05).Conclusion Valsartan combined with salvia tetramethylpyrazine in treatment of early DN was more effective than single valsartan treatment,and no significant adverse reactions was found in combined treatment.Therefore,the combined treatment can be used as a new method for clinical treatment of early DN.
